Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Study of Immunotherapy Combination Regimens for Treating Liver Cancer in Cold Regions

NCT07645209 is registered in ClinicalTrials.gov with Harbin Medical University as lead sponsor.

NCT NCT07645209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07645209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Study of Immunotherapy Combination Regimens for Treating Liver Cancer in Cold Regions
Lead sponsor
Harbin Medical University
Phase
Observational
Overall status
Active, not recruiting
Start date
May 13, 2026
Completion date
May 13, 2029
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer